Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADENOSINE for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 8 adverse event reports in the FDA FAERS database where ADENOSINE was used for Atrial fibrillation.

Most Reported Side Effects for ADENOSINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 265 37.5% 9 167
Off label use 48 6.8% 3 25
Hypotension 42 6.0% 3 20
Product use in unapproved indication 38 5.4% 2 9
Supraventricular tachycardia 38 5.4% 0 21
Ventricular fibrillation 37 5.2% 6 12
Ventricular tachycardia 36 5.1% 2 18
Drug hypersensitivity 33 4.7% 1 0
Cardiac arrest 31 4.4% 6 18
Treatment failure 31 4.4% 0 13
Foetal exposure during pregnancy 29 4.1% 1 4
Drug ineffective for unapproved indication 28 4.0% 1 12
Maternal exposure during pregnancy 27 3.8% 0 10
Tachycardia 27 3.8% 0 19
Dyspnoea 23 3.3% 0 13

Other Indications for ADENOSINE

Supraventricular tachycardia (167) Product used for unknown indication (78) Tachycardia (60) Ventricular tachycardia (58) Atrial tachycardia (29) Arrhythmia (26) Scan myocardial perfusion (24) Cardiac stress test (20) Tachyarrhythmia (10) Cardioversion (8)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

ADENOSINE Full Profile All Atrial fibrillation Drugs ADENOSINE Demographics ADENOSINE Timeline